首页> 外文期刊>International journal of clinical pharmacology and therapeutics >Predictors of functional outcome and hemorrhagic complications in acute ischemic stroke patients treated with intravenous thrombolysis - A retrospective analysis
【24h】

Predictors of functional outcome and hemorrhagic complications in acute ischemic stroke patients treated with intravenous thrombolysis - A retrospective analysis

机译:急性缺血患者静脉溶栓治疗的功能结果和出血性并发症的预测性 - 回顾性分析

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Intravenous thrombolysis (IVT) with recombinant tissue plasminogen activator (rt-PA) within 4.5 hours is an effective and routine therapy for acute ischemic stroke (AIS). The purpose of the study was to identify predictors of functional outcome at 3 months and hemorrhagic complications after IVT. A total of 123 AIS patients treated with intravenous alteplase within 4.5 hours after stroke were enrolled. Baseline clinical characteristics, medication and disease history, radiographic and laboratory data were collected. The clinical functional outcome at 3 months was measured by the modified Rankin Scale dichotomized at 0 - 1 (favorable) vs. 2 - 6 (unfavorable). Hemorrhagic complications were measured within 36 hours after IVT. Univariate and multivariate analysis was applied in the study, and the logistic regression identified the predictors for functional outcome at 3 months and hemorrhagic complications within 36 hours. In univariate analysis, the favorable outcome was significantly associated with short hospitalization, low initial National Institute of Health Stroke Scale scores, previous smoking, previous statin use, and absence of poststroke cerebral edema or pneumonia. Hemorrhagic complications were significantly associated with high initial NIHSS scores, low platelet count, high D-dimer level, previous atrial fibrillation, and onset seasons (except summer). Multivariate regression analyses identified that seasons (spring and summer), short hospital stays, and absence of post-stroke cerebral edema or pneumonia were the predictors of a favorable functional outcome. Meanwhile, seasons (except summer), low platelet count, and high D-dimer levels were correlation factors for prognosis of high hemorrhagic complications.
机译:4.5小时内具有重组组织纤溶酶原激活剂(RT-PA)的静脉溶栓(IVT)是急性缺血性卒中(AIS)的有效和常规治疗。该研究的目的是在IVT后3个月和出血性并发症识别功能结果的预测因子。注册中风后4.5小时内,共有123名AIS患者在4.5小时内用静脉内插粒酶治疗。收集基线临床特征,药物和疾病史,射线照相和实验室数据。通过在0-1(有利)与2 - 6(不利)的改性的Rankin规模的改性Rankin规模测量3个月的临床功能结果。出血性并发症在IVT后36小时内测量。在研究中应用单变量和多变量分析,逻辑回归鉴定了3个月内功能结果的预测因子和36小时内的出血并发症。在单变量分析中,有利的结果与短暂住院,低初始的国家健康冲程量表评分,之前的吸烟,以前的他汀类药物使用以及缺乏失败的脑水肿或肺炎。出血性并发症与高初始NIHSS评分显着相关,低血小板计数,高D-二聚体水平,先前的心房颤动和发病季节(夏季除外)。多元回归分析确定了季节(春夏),短期医院住宿,并且缺乏卒中后脑水肿或肺炎是有利的功能结果的预测因子。同时,季节(夏季除外),低血小板计数和高D二聚体水平是高血膜复杂性预后的相关因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号